Bone biologics corp. announces closing of public offering and uplisting to nasdaq

Burlington, mass.--(business wire)---- $bblg #bonebiologics--bone biologics corp. (nasdaq: bblg) (“bone biologics” or the “company”), a developer of orthobiologic products for spine fusion markets, today announced that it closed a public offering of 1,510,455 units of securities at an offering price of $5.25 per unit, for total gross proceeds of $7.9 million, before deducting underwriting discounts and commissions and other estimated offering expenses. each unit consists of one share of common stock and one warrant to
BBLG Ratings Summary
BBLG Quant Ranking